Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2015

May 19, 2015

30583_dirs_2015-05-19_0b951759-869a-4311-bfbe-0d613b28824f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-05-15

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-15 Common Stock F 1566 $122.78 Disposed 104134 Direct
2015-05-19 Common Stock G 1434 Disposed 102700 Direct
2015-05-19 Common Stock G 1434 Acquired 27670 Indirect

Footnotes

F1: On May 18, 2015 the reporting person gifted 1434 shares of Common Stock to his family trust. The reporting person is the trustee.